Arteris (NASDAQ:AIP) VP Sells $450,322.04 in Stock

Key Points

  • Arteris VP Paul Alpern sold 12,502 shares on June 1 at an average price of $36.02, generating about $450,322 and reducing his stake by 13.46%.
  • The company recently reported better-than-expected quarterly results, posting a smaller-than-expected loss of $0.03 per share and revenue of $22.94 million versus forecasts of $21.03 million.
  • Wall Street sentiment is mixed, with Arteris carrying a Hold consensus rating and an average price target of $37.75, while shares have risen sharply toward their 52-week high of $38.99.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul Alpern sold 12,502 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $36.02, for a total transaction of $450,322.04. Following the transaction, the vice president directly owned 80,384 shares in the company, valued at approximately $2,895,431.68. The trade was a 13.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Arteris Stock Performance

AIP opened at $37.41 on Thursday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The company has a market cap of $1.73 billion, a price-to-earnings ratio of -47.35 and a beta of 1.98. Arteris, Inc. has a 52-week low of $7.56 and a 52-week high of $38.99. The firm's fifty day simple moving average is $26.95 and its two-hundred day simple moving average is $19.63.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.05. The company had revenue of $22.94 million for the quarter, compared to analysts' expectations of $21.03 million. Equities analysts anticipate that Arteris, Inc. will post -0.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Arteris




Institutional investors have recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new position in Arteris during the second quarter worth about $32,000. BNP Paribas Financial Markets raised its stake in Arteris by 75.0% during the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company's stock worth $61,000 after purchasing an additional 2,595 shares during the period. Royal Bank of Canada raised its stake in Arteris by 366.7% during the first quarter. Royal Bank of Canada now owns 4,023 shares of the company's stock worth $66,000 after purchasing an additional 3,161 shares during the period. Strs Ohio purchased a new position in Arteris during the first quarter worth about $104,000. Finally, Penn Capital Management Company LLC purchased a new position in Arteris during the third quarter worth about $109,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AIP has been the topic of several research reports. Weiss Ratings downgraded Arteris from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, May 13th. Jefferies Financial Group raised their target price on Arteris from $16.00 to $35.00 and gave the company a "hold" rating in a research report on Wednesday, May 13th. Wall Street Zen downgraded Arteris from a "buy" rating to a "hold" rating in a research report on Saturday, May 2nd. TD Cowen raised their target price on Arteris from $22.00 to $40.00 and gave the company a "buy" rating in a research report on Wednesday, May 13th. Finally, Northland Securities set a $38.00 target price on Arteris in a research report on Wednesday, May 13th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Arteris currently has an average rating of "Hold" and a consensus price target of $37.75.

Check Out Our Latest Stock Report on Arteris

About Arteris

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Arteris?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Arteris and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles